Lincoln’s YTD Global Healthcare M&A Activity Heralds Record 2019 for the Group
PE Investors Continue to Favor Healthcare for its Non-Cyclical Nature; Strategic Consolidations Continue across the entire Ecosystem
Lincoln International’s Global Healthcare mergers and acquisitions (M&A) activity in 2019 will eclipse that of 2018 led by the firm’s increasing capabilities and strong deal appetites in the sector. Lincoln’s reputation for advising on, executing and closing high-quality assignments across healthcare services, life sciences, pharma outsourcing, medical products and technology continues to strengthen. Lincoln is one of the only middle market investment banks with dedicated, senior healthcare bankers covering markets across North America, Europe, Asia and South America.
YTD 2019, there has been strong interest from both strategic consolidators and private equity investors, driving premium valuations for our clients’ businesses. Private equity investors continue to be aggressive bidders in processes given both the accommodating credit markets and the record levels of equity overhang globally. Lincoln’s Middle Market Index sees healthcare industry valuations up 11.5% year-over-year in Q2 2019.
Looking ahead, we foresee a continuation of the favorable structural fundamentals that have been fueling worldwide healthcare M&A volume and valuations. The forces that create healthcare opportunities are largely independent from broader macroeconomic risks of trade wars, geopolitics, and central bank interest rate policies. Both our on-going dialogues with CEOs and PE executives coupled with a strong and growing pipeline of engaged sell side mandates, further supports our bullish outlook.
We look forward to connecting with you to discuss opportunities in the sector.
Lincoln International Healthcare Team Sees Sustained M&A Growth Ahead in 2020
Lincoln International is pleased to announce that it represented Flexpoint Ford on its acquisition of MGA Homecare
Lincoln International is pleased to announce that ASP Global, LLC has been sold to Incline Equity Partners
Lincoln International has advised IVIRMA in the sale of IVI Middle East, the leading and fastest-growing IVF service provider in the Gulf region, to Gulf Capital
Lincoln International is pleased to announce that the Keystone Capital has sold The Greeley Company to The Chartis Group, a portfolio company of Audax Private Equity
Meet our Senior Team in Healthcare
COVID-19 Pandemic Could Accelerate Recent U.S. Healthcare Growth Trends
One hundred years after the 1918 Spanish Flu, the world is facing another pandemic: COVID-19. Government and healthcare officials are working around the clock to flatten the curve and slow the spread […]
2019 Record Results
The more than 500 global professionals of Lincoln International are pleased to share with you the results of a very successful 2019. Click here to view our 2019 highlights. To explore any […]
Investors Take a Bite into the UK and European Dentistry Markets
Memories of nightmarish childhood trips to the dentist appear to be a thing of the past for investors as they rush to capitalise on the dentistry market in record numbers. Whilst a […]
Lincoln International Adds Michael Siano as Managing Director
Enhances the Firm’s Healthcare Information Technology Advisory Capabilities Lincoln International is pleased to announce the addition of Michael Siano to the firm’s New York office. Having spent close to two decades in […]